Shruthi Narayan

Penumbra EVP & GM Interventional. Family. Medtech. Food. Music. Fashion. Social. Tech.

[Shruthi Narayan @knshruthi]

This is an important moment in the field of VTE. Years of physician collaboration, R&D innovation, and an incredible team of people have made this possible! Excited to introduce the most powerful and advanced mechanical thrombectomy system on the market, ⚡️Lightning Flash⚡️

[Penumbra, Inc. @penumbrainc]

Penumbra launches its latest innovation in mechanical thrombectomy, Lightning Flash. Learn more about this updated catheter design with the latest dual clot detection here: https://t.co/QvxG6grBRV

[Robert A Lookstein MD, MHCDL @roblookstein]

Live @SIRspecialists now that we have published results for STORM-PE and HI-PEITHO there is growing consensus that endovascular therapy should be offered to most ESC Intermediate High Risk or AHA-C3 patients to rapidly improve RV function and prevent clinical deterioration.

[Penumbra Vascular @PenVascular]

US HCPs: Single setting PE and venous thrombectomy completed by Dr. Wiske with Flash 3.0 technology. #CAVT #LightningFlash #SingleSetting

Rx only. Risk: https://t.co/SILdiRZoH4 Clinical results may vary.

[Venkat Tummala MD MBA @t_intheleadcoat]

That’s a wrap for the inaugural @clotsheadtotoe ! It was amazing to participate & witness multidisciplinary conversations around thrombus management #headtotoe! What a stellar faculty at the one & only conference focused solely on CLOTS & that too at the happiest place on Earth!

[Robert A Lookstein MD, MHCDL @roblookstein]

Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes from the STORM-PE Trial | Circulation https://t.co/8eq5gYvkwO

[TCTMD @TCTMD]

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE https://t.co/w2zv5y35qF

[Robert A Lookstein MD, MHCDL @roblookstein]

Honored to work on this incredible project. Thank you so much to all the sites and investigators around the world. Looking forward to sharing the data later this year. @PERTConsortium @SIRspecialists @SCAI @VascularSVS @SVM_tweets

[JNIS @JNIS_BMJ]

Mechanical thrombectomy for DMVOs is gaining traction! In a multicenter study of 102 patients, the RED 43 catheter was found to be safe and effective for distal aspiration. https://t.co/kjsRvNj887 @Nickkhat
#Stroke #DMVO #Thrombectomy #EndovascularTherapy #NeuroIR #Neurointervention

[Shruthi Narayan @knshruthi]

@farkomd 😂😂 good one!

[Robert A Lookstein MD, MHCDL @roblookstein]

Live @PenVascular #STORM-PE investigators meeting with my global Co-PI @RosovskyRachel ….looking forward to completing the first RCT of #CAVT vs #SOC for intermediate-risk PE @SIRspecialists @SCAI @VascularSVS @SVM_tweets @ASH_hematology @PERTConsortium

[Penumbra Vascular @PenVascular]

US HCPs: Congrats to @ic_cooper on this recent PE case utilizing the #Element sheath with #HemoLock technology! Great results with #LightningFlash 2.0 ⚡ #LeadWithCAVT

Rx only. Risk info: https://t.co/SILdiRZWwC Clinical results may vary

[Penumbra Neuro @PenNeuro]

What do physics, vessel sizing, flow control, and time all have in common? They are key components of science-based aspiration thrombectomy (#SBAT). Visit booth #1131 at #ISC2025 to learn how these concepts can inform your approach to stroke care.

[Shruthi Narayan @knshruthi]

@bhwords Thank you for joining us on the panel @bhwords! It was a pleasure to have you.

[The PERT Consortium® @PERTConsortium]

Best science of the year happening at #PERT2024. Come for the science, stay for the game show. First up, @JonnyMoriarty detailing the outcomes of the first 300 patients in STRIKE-PE

[Penumbra Vascular @PenVascular]

Join our Lunch Symposium tomorrow to hear #TheCompletePEStory with a dive into clinical evidence and #CAVT technology for the treatment of PE with Drs. @t_intheleadcoat, Suhail Dohad, @roblookstein, @RosovskyRachel, and @sanjum

[Penumbra Vascular @PenVascular]

Join us on June 22nd to hear Dr. Thomas Maldonado discuss the benefits of endovascular first and the 12-months results from the STRIDE Study! #LightningBolt7 #CAVT #VAM24

[Robert A Lookstein MD, MHCDL @roblookstein]

Very excited to support this study and #STORM-PE to advance the prospective science for treatment of Acute PE @SIRspecialists @SCAI @VascularSVS @SVM_tweets

[Fakhir Elmasri @ElmasriFakhir]

PE with new FLASH 2.0 for the win!
From Non-rebreather —>97% on room air,
PA pressure drop 44–>19mm
& Flouro time 11 mins. At my age I like PE cases under 40 minutes ! #speedyPE #CAVT

@roblookstein @keithppereira @t_intheleadcoat @vaheesanIR @SIRspecialists

[John Moriarty @JonnyMoriarty]

STRIKE-PE data drop: first 150 patients demonstrating improved RV function, low adverse events & improved dyspnoea & QOL! More evidence for PE patients https://t.co/AvmLRGMXSE @SIRspecialists @PERTConsortium @UCLAHealth @uclaVIR @JVIRmedia

[Weill Cornell Medicine Radiology @WCMRadiology]

🎉 EMBOLIZE, a collab b/w @SIRspecialists Foundation & @VIVAPhysicians, in partnership w/ @penumbrainc—a pioneering trial addressing pelvic pain via pelvic venous disease—will be led by national co-PIs @RonaldWinokurMD & @GSalazar_MD. CONGRATULATIONS! 🎉

https://t.co/WWalBAdE33

[Varshana Gurusamy @drvarshana]

During totality 🌑🌒, we experienced our own total eclipse of the heart (or pulmonary arteries) and treated in a Flash ⚡️ @PenVascular